AnaptysBio, Inc. (ANAB) Tops Q2 EPS by 524c
Tweet
Share
E-mail
Get Alerts ANAB Hot Sheet
Join SI Premium – FREE
AnaptysBio, Inc. (NASDAQ: ANAB) reported Q2 EPS of $5.11, $5.24 better than the analyst estimate of ($0.13). Revenue for the quarter came in at $27.5 million versus the consensus estimate of $20.22 million.
For earnings history and earnings-related data on AnaptysBio, Inc. (ANAB) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- JPMorgan Downgrades Shenzhen Inovance Tech (300124:CH) to Neutral
- UBS Downgrades NAVER Corp. (035420:KS) (NHNCF) to Neutral
- Royal Caribbean to acquire 50% stake in Sandals Resorts for $3 billion
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
